NOXXON Pharma N.V. reports 2018 financial results

Heidelberg Pharma AG: Interim management statement on the first three months of 2019

CENTOGENE launches CentoMetabolic™ panel for integrated multiomic testing for metabolic diseases

Unaudited preliminary results for the year ended 31 December 2018

Verona pharma granted key EU patent related to late-stage COPD clinical candidate Ensifentrine

Adocia announces positive topline results for the first clinical study of ADO09, a new co-formulation of pramlintide and a prandial insulin analog, in people with type 1 diabetes

AYOXXA launches LUNARISTM Human and Mouse Chemokine Kits to explore chemokine signaling

Medigene AG: Medigene participates at upcoming conferences

Medigene AG: Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia

MagForce AG: Inauguration ceremony marks official opening of new NanoTherm Treatment Center at Independent Public Clinical Hospital No. 4 in Lublin, Poland